Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 4 , ISSUE 4 ( October-December, 2010 ) > List of Articles

REVIEW ARTICLE

Understanding Biochemical Markers for Antenatal Screening

Keywords : Aneuploidy,Screening,Prenatal diagnosis,Nuchal translucency,Triple test,Quadruple test

Citation Information : Understanding Biochemical Markers for Antenatal Screening. Donald School J Ultrasound Obstet Gynecol 2010; 4 (4):333-335.

DOI: 10.5005/jp-journals-10009-1153

License: CC BY-NC 4.0

Published Online: 01-06-2011

Copyright Statement:  Copyright © 2010; The Author(s).


Abstract

Screening tests to identify fetuses at risk for aneuploidies should be offered to all pregnant women.

It should be remembered that screening tests can not diagnose a birth defect; they can only indicate an increased risk. An abnormal screening test result simply mean that additional testing is recommended.

Maternal serum biochemical markers in first trimester are free beta-hCG and PAPP-A. In second trimester the markers are AFP, UE3, hCG (Triple test) and inhibin added to these three markers forming the quadruple test. Level of cell free fetal DNA and fetal cells in maternal circulation are some of the molecular techniques for prenatal diagnosis of aneuploidies.

PDF Share
  1. Aneuploidy screening in the first trimester. Am J Med Genet Part C Semin Med Genet 2007;145C:18-32.
  2. Study of malformations and Down's syndrome in India: A multicentric study. Department of Atomic Energy. Bhabha Atomic Research Center, Trombay. Mumbai 1998.
  3. ACOG Practice bulletin number 88: Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110:1459-66.
  4. Prenatal screening for neural tube defects and aneuploidics. In: Remion DL, Connor JM, Pyeritz RE, Korf BR (Eds). Principles and Practice of Medical Genetics. Churchill Livingstone 2002:763-801.
  5. Screening of maternal scrum for fetal Down's syndrome in the first trimester. N Eng J Med 1998;338;955-61.
  6. Routine ultrasound scanning before. 24 weeks of pregnancy. Health technology assessment report; NHS quality improvement scotland, 2003.
  7. First and second trimester antenatal screening for Down's syndrome. The results of serum, urine and ultrasound screening study (SURUSS). Health Technol Assess 2003;7:1-77.
  8. “An Introduction to Genetics and Fetal Medicine (2nd ed). 2010 Page No. 48, 49204, 205.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.